Clinical Trials Browser

Phase 2 × Lymphoma, Extranodal NK-T-Cell × Basiliximab × Clear all

NCT04337593 2020-04-07

Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCL

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell